Tapimmune, Inc.
We are investigating Tapimmune, Inc. (“Tapimmune” or the “Company”) (NasdaqCM: TPIV) relating to the sale of the Company to a group of institutional investors. Under the terms of the agreement,TapImmune Inc. (the “Company”) entered into Securities Purchase Agreements (the “Securities Purchase Agreements”) for a private placement (the “Private Placement”) with a select group of institutional … Read more